This inventor holds 4 USPTO granted patents. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1986-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Uji, JP (1986 - 1987)
- Kyoto, JP (1994)
Company Filing History:
Years Active: 1986-1994
Title: Innovations by Yoshitaka Ohishi
Introduction
Yoshitaka Ohishi is a notable inventor based in Uji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. With a total of 4 patents to his name, his work has garnered attention in the scientific community.
Latest Patents
Ohishi's latest patents include innovative compounds such as bisphosphonic acid derivatives, which serve as bone resorption inhibitors. These derivatives are designed to improve bone health and prevent conditions related to bone loss. Another significant patent involves benzofuran derivatives that are useful in treating diabetic complications. These compounds exhibit powerful activities, including aldose reductase inhibition and platelet aggregation inhibition, making them valuable in the management of diabetes-related health issues.
Career Highlights
Yoshitaka Ohishi is currently associated with Kaken Pharmaceutical Company, Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical industry.
Collaborations
Ohishi has collaborated with esteemed colleagues such as Michiko Nagahara and Norio Kajikawa. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and scope of his research.
Conclusion
Yoshitaka Ohishi's innovative work in pharmaceuticals highlights his commitment to improving health outcomes through scientific research. His contributions, particularly in the development of new therapeutic compounds, underscore the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
